Abiopharma

🔍 Dodge R Stanton (Executive)

Company: DraftKings Inc. (DKNG)

Report Date: 2026-05-01

Detailed Transactions and Holdings:

• Acquired 1,475 shares of Class A Common Stock (Direct)
  Date: 2026-05-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 537,375.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 646 shares of Class A Common Stock at $23.0 per share (Direct)
  Date: 2026-05-01 | Code: F | equity_swap_involved: 0 | shares_owned_after: 536,729.00 | transaction_form_type: 4
• Sold 1,475 shares of Restricted Stock Units (Derivative)
  Date: 2026-05-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 14,756.00 | transaction_form_type: 4 | Footnotes: F1, F2, F2

Footnotes:

• F1: No shares of Class A Common Stock were transferred or sold upon the vesting of the restricted stock units ("RSUs") other than to the Issuer to satisfy withholding taxes. The Reporting Person received the net of the 1,475 shares of Class A Common Stock underlying the RSUs listed in Table II, and 646 shares of Class A Common Stock withheld by the Issuer. Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock.
• F2: On February 17, 2026, the Reporting Person was granted 17,707 RSUs vesting monthly over (1) year from March 1, 2026.